The prevalence of autism spectrum disorders (ASD) among adults in the United States is rising rapidly, according to a new study.

Eric Rubenstein and colleagues analyzed a random sample of Medicaid records from 2011 through 2019, identifying individuals 18 years of age or older with a diagnosis of autism. They report, “In this cohort study of 403,028 Medicaid enrollees with autism claims over nine years of claims data, autism prevalence increased from 4.2 per 1,000 enrollees in 2011 to 9.5 per 1,000 enrollees in 2019. The largest increase was observed in the 25- to 34-year age group and the smallest increase in the 55- to 64-year age group.” The percentage of Medicaid enrollees with ASD who also had intellectual disability (ID) dropped from 62 percent in 2011 to 46 percent in 2019, potentially indicating a greater awareness of autism in individuals without ID.
The researchers conclude, “These findings suggest that despite difficulties in identifying autism in adults, there is a considerable and growing population of autistic adults among Medicaid enrollees, which may have future implications for the Medicaid system and understanding the needs of the autistic population.”
This article originally appeared in Autism Research Review International, Vol. 37, No. 4, 2023
How To Pursue an Autism Diagnosis as an Adult – From the Cleveland Clinic
Editorial: What we breathe matters – Rethinking air pollution and autism
For nearly sixty years, the Autism Research Institute (ARI) has tried to understand autism by looking beyond surface behaviors and asking deeper biological questions. From the beginning, Bernard Rimland challenged the dominant
Editorial: Invisible threats – the role of environmental toxins in autism
As our knowledge about autism continues to evolve, so does our understanding of its root causes. For many years, professionals blamed “refrigerator parents” and prescribed psychoanalytic therapy. Once the psychogenic theory was
ARI’s 2025 Impact
Advocating for Independent Research and Education For nearly six decades, ARI has funded groundbreaking research, expanded educational initiatives, and brought clinicians and scientists together worldwide. Yet researchers and clinicians continue to face unprecedented


